Correlation Between LG Household and INtRON Biotechnology
Can any of the company-specific risk be diversified away by investing in both LG Household and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LG Household and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LG Household Healthcare and iNtRON Biotechnology, you can compare the effects of market volatilities on LG Household and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LG Household with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of LG Household and INtRON Biotechnology.
Diversification Opportunities for LG Household and INtRON Biotechnology
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 051905 and INtRON is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding LG Household Healthcare and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and LG Household is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LG Household Healthcare are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of LG Household i.e., LG Household and INtRON Biotechnology go up and down completely randomly.
Pair Corralation between LG Household and INtRON Biotechnology
Assuming the 90 days trading horizon LG Household Healthcare is expected to generate 0.73 times more return on investment than INtRON Biotechnology. However, LG Household Healthcare is 1.37 times less risky than INtRON Biotechnology. It trades about -0.01 of its potential returns per unit of risk. iNtRON Biotechnology is currently generating about -0.07 per unit of risk. If you would invest 15,500,000 in LG Household Healthcare on September 13, 2024 and sell it today you would lose (1,540,000) from holding LG Household Healthcare or give up 9.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
LG Household Healthcare vs. iNtRON Biotechnology
Performance |
Timeline |
LG Household Healthcare |
iNtRON Biotechnology |
LG Household and INtRON Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LG Household and INtRON Biotechnology
The main advantage of trading using opposite LG Household and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LG Household position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.LG Household vs. iNtRON Biotechnology | LG Household vs. Jeju Air Co | LG Household vs. Ssangyong Information Communication | LG Household vs. Mobileleader CoLtd |
INtRON Biotechnology vs. Medy Tox | INtRON Biotechnology vs. Oscotec | INtRON Biotechnology vs. Genexine | INtRON Biotechnology vs. Helixmith Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |